Terumo Corporation drugs
19 results
Imuflex wb-rp blood bag system with integral whole blood leukocyte reduction filter (removing platelets) with diversion blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) red cell preservative (anticoagulant citrate phosphate dextrose (cpd) and as-5 red cell preservative)
(Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative)Terumo Corporation
Usage: This drug is indicated for the collection, processing, and preservation of Whole Blood and blood components (500 mL ±10%). It is not for intravenous infusion and includes features for donor sample collection and leukocyte reduction within 8 hours post-collection under specified storage conditions.
Imuflex wb-sp blood bag system with integral whole blood leukocyte reduction filter (saving platelets) with diversion blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) red cell preservative for collection of 500ml of blood (anticoagulant citrate phosphate dextrose (cpd) and as-5 red cell preservative)
(Anticoagulant Citrate Phosphate Dextrose (CPD) and AS-5 Red Cell Preservative)Terumo Corporation
Usage: This drug is indicated for the collection, processing, and preservation of Whole Blood and its components. It includes features for donor sample testing and leukocyte reduction, intended for use with 500 mL ±10% Whole Blood. It is not for direct intravenous infusion.
Imuflex wb-sp blood bag system with integral whole blood leukocyte reduction filter (saving platelets) with diversion blood sampling arm (anticoagulant citrate phosphate dextrose (cpd))
(Anticoagulant Citrate Phosphate Dextrose (CPD))Terumo Corporation
Usage: This drug is indicated for the collection, processing, and preservation of Whole Blood (500 mL ±10%). It includes a diversion sampling arm for pre-collection donor testing and a filter unit for leukocyte reduction within 8 hours of collection at ambient temperature. Not for direct intravenous infusion.
Teruflex blood anticoagulant citrate phosphate dextrose adenine (cpda-1) for collection of 450ml of blood (anhydrous citric acid, trisodium citrate dihydrate, sodium phosphate, monobasic, monohydrate, dextrose monohydrate, and adenine)
(Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine)Terumo Corporation
Usage: This drug is indicated for the collection, processing, and preservation of Whole Blood and its components. It is not for direct intravenous infusion and accommodates 450 mL or 500 mL collections. It also includes a diversion sampling arm for donor testing prior to blood collection.
Teruflex blood bag system anticoagulant citrate phosphate dextrose (cpd) and optisol red cell preservative (anticoagulant citrate phosphate dextrose (cpd) and as-5 red cell preservative)
(Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative)Terumo Corporation
Usage: The TERUFLEX® Blood Bag System is intended for collecting 250 mL of whole blood from smaller autologous donors, such as pediatric or elderly patients. It facilitates blood collection as directed by a physician, allowing the preparation of autologous platelets, though regulatory platelet concentration may not be met.
Teruflex blood bag system anticoagulant citrate phosphate dextrose (cpd) and optisol red cell preservative (anticoagulant citrate phosphate dextrose (cpd) and as-5 red cell preservative)
(Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative)Terumo Corporation
Usage: TERUFLEX® Blood Bag System with CPD/OPTISOL® Solution is indicated for the collection, processing, and storage of blood components, specifically red blood cells, for transfusion. It ensures effective mixing with anticoagulants and supports various processing options to maintain blood product integrity for up to 42 days.
Teruflex blood bag system anticoagulant citrate phosphate dextrose adenine (cpda-1) (anticoagulant citrate phosphate dextrose adenine (cpda-1))
(Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1))Terumo Corporation
Usage: The drug is indicated for the collection, processing, and preservation of 250 mL of Whole Blood from elderly, pediatric, or smaller autologous donors. It is not intended for direct intravenous infusion or for the production of platelets and plasma. Collection should follow physician directives.
Teruflex blood bag system anticoagulant citrate phosphate dextrose adenine (cpda-1) (anticoagulant citrate phosphate dextrose adenine (cpda-1))
(Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1))Terumo Corporation
Usage: The drug is indicated for the collection, processing, and preservation of whole blood and blood components (450 mL +/- 10%). It is not intended for direct intravenous infusion and should be used with standard component processing techniques.
Teruflex blood bag system anticoagulant citrate phosphate dextrose adenine (cpda-1) (anticoagulant citrate phosphate dextrose adenine (cpda-1))
(Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1))Terumo Corporation
Usage: The Teruflex Blood Bag System with Diversion Blood Sampling Arm is intended for the collection, processing, and preservation of whole blood (450 mL and 500 mL). It diverts samples for laboratory testing before blood collection and is not designed for direct intravenous infusion.
Teruflex blood bag system with blood sampling arm anticoagulant citrate phosphate dextrose (cpd) and optisol (as-5) red cell preservative (anticoagulant citrate phosphate dextrose (cpd) and as-5 red cell preservative)
(Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative)Terumo Corporation
Usage: TERUFLEX® Blood Bag System is indicated for the collection, storage, and processing of blood and its components. The system facilitates blood sampling and ensures proper anticoagulation, allowing for red cell separation and preservation for subsequent transfusion within specified time frames.